Literature DB >> 8331352

The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.

N Turjanski1, W Fernandez, A J Lees.   

Abstract

The effects of acute levodopa withdrawal were studied in nine patients with levodopa related on-off oscillations. One patient withdrew from the study due to off period confusion and hallucinations. A marked deterioration in motor disability occurred in all patients following overnight withdrawal of levodopa and a further mild delayed deterioration was present over a mean withdrawal period of 44 hours. Patients with more severe disease were able to tolerate levodopa withdrawal for a shorter period of time than those with milder disease severity. The minimum therapeutic dose of subcutaneous apomorphine needed to produce a similar improvement in patients' mobility, before and after several days of drug withdrawal, did not differ, thus providing no clinical evidence for alterations in striatal dopamine receptor sensitivity after acute levodopa withdrawal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331352      PMCID: PMC1015058          DOI: 10.1136/jnnp.56.7.771

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.

Authors:  K L Leenders; A J Palmer; N Quinn; J C Clark; G Firnau; E S Garnett; C Nahmias; T Jones; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

2.  Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.

Authors:  H Nissenbaum; N P Quinn; R G Brown; B Toone; A M Gotham; C D Marsden
Journal:  Psychol Med       Date:  1987-11       Impact factor: 7.723

Review 3.  'Drug holidays' in the treatment of Parkinson's disease. A brief review.

Authors:  J H Friedman
Journal:  Arch Intern Med       Date:  1985-05

4.  Fatal hyperpyrexia after withdrawal of levodopa.

Authors:  G P Sechi; F Tanda; R Mutani
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

5.  Levodopa-free periods ("drug holidays") in the management of parkinsonism.

Authors:  H L Klawans; C G Goetz; C M Tanner; P A Nausieda; W J Weiner
Journal:  Adv Neurol       Date:  1983

6.  Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease.

Authors:  R Mayeux; Y Stern; K Mulvey; L Cote
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

7.  Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.

Authors:  M Suga
Journal:  Life Sci       Date:  1980-09-08       Impact factor: 5.037

8.  Drug holiday and management of Parkinson disease.

Authors:  W J Weiner; W C Koller; S Perlik; P A Nausieda; H L Klawans
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

9.  The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.

Authors:  A Reches; H R Wagner; D Jiang; V Jackson; S Fahn
Journal:  Life Sci       Date:  1982-07-05       Impact factor: 5.037

10.  Weekly drug holiday in Parkinson disease.

Authors:  C G Goetz; C M Tanner; P A Nausieda
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

View more
  3 in total

Review 1.  Concentration-effect relationship of levodopa in patients with Parkinson's disease.

Authors:  S Harder; H Baas; S Rietbrock
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

2.  Disentangling motor planning and motor execution in unmedicated de novo Parkinson's disease patients: An fMRI study.

Authors:  Jason A Martin; Nadine Zimmermann; Lukas Scheef; Jakob Jankowski; Sebastian Paus; Hans H Schild; Thomas Klockgether; Henning Boecker
Journal:  Neuroimage Clin       Date:  2019-03-19       Impact factor: 4.881

Review 3.  Implications of dopaminergic medication withdrawal in Parkinson's disease.

Authors:  J Koschel; K Ray Chaudhuri; L Tönges; M Thiel; V Raeder; W H Jost
Journal:  J Neural Transm (Vienna)       Date:  2021-07-29       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.